Rotavirus Vaccine
- Atc Codes:J07BH01
Table of contents
- Brand Names
- Pharmacologic Category
- Mechanism of Action
- Therapeutic Use
- Pregnancy and Lactation Implications
- Contraindications
- Warnings and Precautions
- Adverse Reactions
- Drug Interactions
- Dosage
Brand Names
Europe
Austria: Rotarix, RotaTeq; Belgium: Rotarix, RotaTeq; Bulgaria: Rotarix, RotaTeq; Cyprus: Rotarix, RotaTeq; Czech Republic: Rotarix, RotaTeq; Denmark: Rotarix, RotaTeq; Estonia: Rotarix, RotaTeq; Finland: Rotarix, RotaTeq; France: Rotarix, RotaTeq; Germany: Rotarix, RotaTeq; Hungary: Rotarix, RotaTeq; Ireland: Rotarix, RotaTeq; Italy: Rotarix, RotaTeq; Latvia: Rotarix, RotaTeq; Lithuania: Rotarix, RotaTeq; Luxembourg: Rotarix, RotaTeq; Malta: Rotarix, RotaTeq; Netherlands: Rotarix; Poland: Rotarix, RotaTeq; Portugal: Rotarix, RotaTeq; Romania: Rotarix, RotaTeq; Slovakia: Rotarix, RotaTeq; Slovenia: Rotarix, RotaTeq; Spain: RotaTeq; Sweden: RotaTeq; UK: Rotarix.
North America
Canada: Rotarix, RotaTeq; USA: Rotarix, RotaTeq.
Latin America
Argentina: Rotarix, RotaTeq; Brazil: Vacina Contra Rotavirus; Mexico: Rotarix.
Drug combinations
Chemistry
Pharmacologic Category
Serums, Toxoids, and Vaccines; Vaccines. Live Viral Vaccine. (ATC-Code: J07BH01/2).
Mechanism of action
Replicates in small intestine and promotes active immunity to rotavirus gastroenteritis.
Therapeutic use
Prevention of rotavirus gastroenteritis in infants and children.
Pregnancy and lactiation implications
Not indicated for use in women of reproductive age. Infants living in households with pregnant women may be vaccinated. Infants receiving vaccine may be breast-fed.
Unlabeled use
Contraindications
Hypersensitivity to rotavirus vaccine or any component of the formulation. Contraindicated with history of uncorrected congenital malformation of GI tract.
Warnings and precautions
Anaphylactoid and/or hypersensitivity reactions might occur. Use caution with history of intussusception. May be administered in mild acute illness (with or without fever). Use with caution in infants with history of GI disorders, acute GI illness, chronic diarrhea, failure to thrive, congenital abdominal disorders, abdominal surgery, and intussusception. Vaccine may be used with controlled gastroesophageal reflux disease. Consider delaying administration to infants with acute diarrhea or vomiting. Oral suspension contraindicated with history of uncorrected congenital malformation of GI tract. Use with caution in presence of immunocompromised family members.